Blockade of monoamine uptake by 1-amino-4-phenylbicyclo(2,2,2)octane (EXP 561) in rat brain and heart.
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D003864:Depression, Chemical; D004347:Drug Interactions; D006892:Hydroxydopamines / Q000633:toxicity; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism; D010133:p-Chloroamphetamine / Q000633:toxicity
D001679:Biogenic Amines; D001643:Bridged Bicyclo Compounds; D001952:Bridged-Ring Compounds; D006892:Hydroxydopamines; C013358:EXP561; D012701:Serotonin; D010133:p-Chloroamphetamine